Results 151 to 160 of about 191,956 (212)
Working together: a multi-component intranasal vaccine provides synergistic protection against COVID-19. [PDF]
Breznik JA, Verschoor CP.
europepmc +1 more source
Yeast vaccine production platform for human and animal infectious diseases. [PDF]
Ramos-Vega A +5 more
europepmc +1 more source
Protective efficacy of a genetically modified attenuated vaccinia virus Tiantan strain against monkeypox virus challenge in a small animal model. [PDF]
Su W +8 more
europepmc +1 more source
The construction of recombinant DNA vaccine pVAX-ROP27-IL-2-IFN-γ and its immune enhancement effect against Eimeria tenella. [PDF]
Niu Z +9 more
europepmc +1 more source
Carbohydrate fatty acid monosulphate ester adjuvant enhances the immunogenicity of influenza antigens <i>via</i> TLR4/2-dependent mechanisms. [PDF]
Retnakumar SV +10 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Recombinant bacterial vaccines
Current Opinion in Immunology, 2012Vaccines are currently available for many infectious diseases caused by several microbes and the prevention of disease and death by vaccination has profoundly improved public health globally. However, vaccines are not yet licensed for use against many other infectious diseases and new or improved vaccines are needed to replace suboptimal vaccines, and ...
Meera, Unnikrishnan +2 more
openaire +2 more sources
Recombinant vaccines against Leptospirosis
Human Vaccines, 2011Leptospirosis is an important neglected infectious disease that occurs in urban environments, as well as in rural regions worldwide. Rodents, the principal reservoir hosts of pathogenic Leptospira spp., and other infected animals shed the bacteria in their urine.
Odir A, Dellagostin +5 more
openaire +2 more sources

